Maze Therapeutics, Inc. (MAZE) vs Syndax Pharmaceuticals, Inc. (SNDX)
A side-by-side comparison of Maze Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MAZE
Maze Therapeutics, Inc.
$26.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SNDX
Syndax Pharmaceuticals, Inc.
$17.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MAZE vs SNDX
growth of $100 · dividends reinvested · last 2yMAZE +65.7% (+28.7%/yr)SNDX +25.2% (+11.9%/yr)MAZE compounded faster over this window
MAZE SNDX
MAZE vs SNDX: by the numbers
- •SNDX is the larger company ($1.54B vs $1.46B market cap).
- •Both run net losses; SNDX's is the smaller (-87.60% vs -667.95% net margin).
Metrics side by side
Valuation
| Metric | MAZE | SNDX |
|---|---|---|
| P/S ratio | 73.14 | 6.11 |
| P/B ratio | 3.23 | 101.94 |
Profitability
| Metric | MAZE | SNDX |
|---|---|---|
| Gross margin | 0.00% | 97.47% |
| Operating margin | 0.00% | -158.45% |
| Net margin | -667.95% | -87.60% |
| ROE | -29.48% | -1462.12% |
| ROIC | -28.63% | -32.15% |
Growth (annualized)
| Metric | MAZE | SNDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 178.06% |
| Total return CAGR (5Y) | N/A | -0.01% |
Go deeper
Dig into the metrics
Maze Therapeutics ROESyndax Pharmaceuticals ROEMaze Therapeutics operating marginSyndax Pharmaceuticals operating marginMaze Therapeutics revenue growthSyndax Pharmaceuticals revenue growthMaze Therapeutics free cash flowSyndax Pharmaceuticals free cash flow
Maze Therapeutics & Syndax Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.